DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
- · 19d
- Not stated
- 6
- May 4, 2026
Official announcement on grants_gov · opens the funder's page. Always confirm dates there.
Summary
The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. […]
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- The review-criteria section of this announcement, extracted in full
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards